Castaldo Stéphanie Anaís, Freitas Joana Raquel, Conchinha Nadine Vasconcelos, Madureira Patrícia Alexandra
Centre for Biomedical Research (CBMR), University of Algarve, Campus of Gambelas, Building 8, Room 2.22, 8055-139 Faro, Portugal.
Oxid Med Cell Longev. 2016;2016:8413032. doi: 10.1155/2016/8413032. Epub 2015 Nov 22.
The cellular REDOX regulatory systems play a central role in maintaining REDOX homeostasis that is crucial for cell integrity, survival, and proliferation. To date, a substantial amount of data has demonstrated that cancer cells typically undergo increasing oxidative stress as the tumor develops, upregulating these important antioxidant systems in order to survive, proliferate, and metastasize under these extreme oxidative stress conditions. Since a large number of chemotherapeutic agents currently used in the clinic rely on the induction of ROS overload or change of ROS quality to kill the tumor, the cancer cell REDOX adaptation represents a significant obstacle to conventional chemotherapy. In this review we will first examine the different factors that contribute to the enhanced oxidative stress generally observed within the tumor microenvironment. We will then make a comprehensive assessment of the current literature regarding the main antioxidant proteins and systems that have been shown to be positively associated with tumor progression and chemoresistance. Finally we will make an analysis of commonly used chemotherapeutic drugs that induce ROS. The current knowledge of cancer cell REDOX adaptation raises the issue of developing novel and more effective therapies for these tumors that are usually resistant to conventional ROS inducing chemotherapy.
细胞氧化还原调节系统在维持氧化还原稳态中发挥核心作用,而氧化还原稳态对于细胞完整性、存活及增殖至关重要。迄今为止,大量数据表明,随着肿瘤发展,癌细胞通常会经历越来越严重的氧化应激,从而上调这些重要的抗氧化系统,以便在这些极端氧化应激条件下存活、增殖和转移。由于目前临床上使用的大量化疗药物依赖于诱导活性氧(ROS)过载或改变ROS性质来杀死肿瘤,癌细胞的氧化还原适应成为传统化疗的重大障碍。在本综述中,我们首先将研究导致肿瘤微环境中普遍观察到的氧化应激增强的不同因素。然后,我们将对当前有关已被证明与肿瘤进展和化疗耐药性呈正相关的主要抗氧化蛋白和系统的文献进行全面评估。最后,我们将分析诱导ROS的常用化疗药物。目前对癌细胞氧化还原适应的认识提出了为这些通常对传统ROS诱导化疗耐药的肿瘤开发新颖且更有效疗法的问题。